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Glycosylphosphatidylinositol (GPI) anchoring is
important for the function of several proteins in the
context of their membrane traf®cking pathways.
We have shown previously that endocytosed GPI-
anchored proteins (GPI-APs) are recycled to the
plasma membrane three times more slowly than other
membrane components. Recently, we found that GPI-
APs are delivered to endocytic organelles, devoid of
markers of the clathrin-mediated pathway, prior to
their delivery to a common recycling endosomal com-
partment (REC). Here we show that the rate-limiting
step in the recycling of GPI-APs is their slow exit
from the REC; replacement of the GPI anchor with a
transmembrane protein sequence abolishes retention
in this compartment. Depletion of endogenous
sphingolipid levels using sphingolipid synthesis inhibi-
tors or in a sphingolipid-synthesis mutant cell line spe-
ci®cally enhances the rate of endocytic recycling of
GPI-APs to that of other membrane components. We
have shown previously that endocytic retention of
GPI-APs is also relieved by cholesterol depletion.
These ®ndings strongly suggest that functional reten-
tion of GPI-APs in the REC occurs via their associ-
ation with sphingolipid and cholesterol-enriched
sorting platforms or `rafts'.
Keywords: endocytosis/GPI-anchored proteins/rafts/
sorting/sphingolipids
Introduction
Glycosylphosphatidylinositol-anchored proteins (GPI-
APs) are a large class of functionally diverse proteins
that share an evolutionarily conserved C-terminal post-
translational lipid modi®cation, the GPI moiety
(McConville and Ferguson, 1993). Besides acting as the
sole means of anchorage for these proteins at the
extracellular lea¯et of the plasma membrane, this modi-
®cation appears to be responsible for GPI-APs being
apically targeted in polarized epithelia, and for transdu-
cing signals across bilayers (for review see Lisanti et al.,
1990; Ferguson, 1994; Robinson, 1997).
GPI-APs appear to be internalized via a non-clathrin-
mediated endocytic route (Bamezai et al., 1992; Keller
et al., 1992; Ricci et al., 2000; Sabharanjak and Mayor,
1999; Skretting et al., 1999). We have found recently that
they are delivered to peripheral tubular-vesicular endo-
somes called GEECs (GPI-AP enriched endosomal com-
partments), devoid of markers of the clathrin-mediated
pathway (Sabharanjak and Mayor, 1999; S.Sabharanjak
and S.Mayor, in preparation). These endosomal orga-
nelles, which contain a signi®cant fraction of internalized
¯uid phase, deliver GPI-APs to the pericentriolar recycling
endosomal compartment (REC). GPI-APs are not deliv-
ered to late endosomes, consistent with observations made
in earlier studies (Kamen et al., 1988; Keller et al., 1992;
Rijnboutt et al., 1996; Mayor et al., 1998). In the well
characterized clathrin-mediated endocytic pathway, endo-
cytosed molecules are delivered to sorting endosomes and
then traf®c to the REC or late endosomes (Gruenberg and
Max®eld, 1995; Mukherjee et al., 1997).
After reaching the REC, recycling to the cell surface
does not seem to be mediated by any speci®c signal:
transferrin receptor (TfR), N-terminally truncated TfR
lacking its cytoplasmic tail (d3±59TfR) (Johnson et al.,
1993; Marsh et al., 1995) and a ¯uorescent lipid inserted in
the exoplasmic lea¯et of the plasma membrane (Mayor
et al., 1993) are recycled to the cell surface at a similar
rate. However, GPI-APs recycle to the cell surface three
to four times more slowly (t1/2 ~30 min) than other
components of the recycled membrane (t1/2 ~8 min)
(Mayor et al., 1998), thereby accumulating inside cells for
much longer than other components of the recycling
membrane. The rate-limiting step in endocytic recycling
may occur in either the GEECs or the REC, with different
implications for the mechanism of endocytic traf®cking of
GPI-APs. If the rate-limiting step in recycling is exit from
GEECs, this would suggest that the slower recycling of
GPI-APs to the plasma membrane is a result of the
characteristic traf®cking property of the GEECs. On the
other hand, if exit from REC is rate limiting, then GPI-APs
would have to be sorted/segregated from recycling
receptors and other membrane components in the REC.
Essential functions of many GPI-APs are likely to be
mediated by endocytic retention. For example, folate
uptake via the human folate receptor (FR-GPI) is severely
impaired in cholesterol-depleted cells (Chang et al., 1992)
in which FR-GPI is no longer retained in endosomes
(Mayor et al., 1998). Folate uptake via FR-GPI is also
severely impaired upon depletion of sphingolipids by
treatment of cells with Fumonisin B1 (FB1), a fungal
metabolite from Fusarium moniliforme, which inhibits
sphingosine N-acyl-transferase (Stevens and Tang, 1997).
It is likely that sphingolipid levels in cells could also
in¯uence endocytic retention of GPI-APs in a manner
similar to cholesterol.
In this report, we have used monovalent ¯uorescent
ligands to compare the endocytic route and kinetics of
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traf®cking of GPI-APs and FR isoforms lacking GPI
anchors, with a marker of the clathrin-pit-mediated
pathway, TfR. We have identi®ed the site at which
endocytic retention of GPI-AP takes place: retention
occurs in the REC and requires the presence of the GPI
anchor. We have shown previously that cholesterol
depletion abolishes endocytic retention of GPI-APs
(Mayor et al., 1998), and here we have examined the
role of sphingolipids in the endocytic recycling of GPI-
APs. We show that sphingolipids are necessary for the
retention of GPI-APs in the REC; depletion of sphingo-
lipids dramatically increases the rate of recycling of GPI-
APs from the REC. These results, taken together, strongly
suggest that the endocytic retention of GPI-APs is
mediated by cholesterol and sphingolipid-dependent
entities called `rafts' (Simons and Ikonen, 1997).
Results
GPI anchoring leads to endocytic retention in the
pericentriolar REC
FR-GPI and GPI-anchored decay accelerating factor
(DAF) are extensively co-localized with TfR in the REC
as previously observed by horseradish peroxidase (HRP)-
mediated quenching and immunoelectron microscopy
(EM) methodologies, respectively (Mayor et al., 1998).
Despite this extensive co-localization, a signi®cant frac-
tion of the internalized GPI-AP pool is consistently
separate from TfR (Mayor et al., 1998). Accumulation
of GPI-APs in GEECs (S.Sabharanjak and S.Mayor, in
preparation) provides an explanation for the lack of co-
localization of a fraction of internalized GPI-APs with
TfR-containing endosomes (Mayor et al., 1998). This
fraction of GPI-APs co-localizes with ¯uid-phase markers
but not with Tf or low-density lipoproteins (LDLs) that are
internalized into sorting endosomes (data not shown).
To identify the rate-limiting step in the recycling of
GPI-APs to the cell surface, we measured the rates of exit
of GPI-APs from the GEECs and the REC (Figure 1). As
described by Mayor et al. (1998), the rate of approach to
steady state is a measure of the rate of exit from a
kinetically de®ned compartment. Therefore, we measured
the rate of approach to steady state of internalized FR-
GPI ligand, Na-pteroyl-Ne-(4¢-rhodamine-thiocarbamoyl)-
L-lysine (PLR), in the REC and the GEECs, identi®ed as
described in Materials and methods. The amount of FR-
GPI, as measured by the extent of PLR ¯uorescence in the
peripheral GEECs (Figure 1A and B; arrows), remained
unchanged between the 20 and 60 min time points,
whereas there was a dramatic increase in PLR ¯uorescence
in the REC between the 20 and 60 min time points
(Figure 1A and B; arrowheads). Kinetic analyses of these
data show that FR-GPI reaches steady state in the GEECs
much earlier than in the REC (Figure 1E). The kinetics of
exit of FR-GPI from the GEECs and the REC are well
described as a ®rst-order process (Figure 1E, lines
represent the theoretical ®t; R >0.98), although we can
not rule out undetected contributions from additional
processes. The t1/2 of exit from the GEECs is ~13 min (ke
0.05 min±1) while that from the REC is ~30 min (ke 0.022
min±1) (Figure 1F). Since the t1/2 for recycling of FR-GPI
to the cell surface measured in the same experiment is also
30 min (ke 0.023 min±1; Figure 1F, see also Table II), these
data show that the rate-limiting step in the recycling of the
internalized GPI-APs is their exit from REC. The slow rate
of recycling of GPI-APs results in the accumulation of
GPI-APs in the REC for extended times, con®rming that
GPI-APs are sorted/segregated from other recycling
membrane components in the REC.
To examine whether this manifestation of endocytic
sorting, namely retention in the REC, is mediated by the
presence of the GPI anchor, we compared the extent of
accumulation of FR-GPI and two isoforms of FR, FR-TM
and FR-TA, lacking the GPI anchor. FR-TM has the
folate-binding portion fused to the transmembrane region
of the Fc receptor and the cytoplasmic tail of the LDL
receptor (Varma and Mayor, 1998), and FR-TA bears
the same transmembrane and cytoplasmic tail region as
Fig. 1. Traf®cking kinetics of FR-GPI measured in endocytic
compartments of CHO cells. FRaTb-1 cells were incubated with PLR
to determine the extent of accumulation of endocytosed FR-GPI in the
peripheral GEECs (arrows) and the pericentriolar REC (arrowheads)
after a 20 (A) or 60 min (B) pulse of the label (see Materials and
methods). (A) and (B) show gray-scale intensities of endocytosed PLR
normalized to surface FR-GPI expression. The bar shows a gradient of
gray-scale intensities with the lowest (black) at the bottom of the bar to
the highest (white) at the top of the bar. (C and D) REC-localized Cy5-
Tf images of the same cells in (A) and (B), obtained as described in
Materials and methods. The REC is marked with a white boundary for
two representative cells. Scale bar represents 5 mm. (E) Change in
surface receptor-normalized ¯uorescence in intracellular compartments
plotted against time of incubation for the total endosomal FR-GPI
(open squares), FR-GPI in REC (open triangle) and FR-GPI in GEECs
(®lled circles). The lines represent the best ®t for the data points using
the kinetic equation described in Materials and methods. Note that
GEECs reach a steady state of PLR labeling much more quickly than
the REC or the total endosomal receptors. (F) Rate constant of exit (ke)
from the indicated compartments.
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FR-TM but has three critical tyrosines mutated to alanine,
rendering it incapable of being recognized by a cytoplas-
mic sorting machinery (Matter et al., 1993). As described
above and shown in Figure 2A, FR-GPI continues to
accumulate in TfR-containing REC, while the distribution
and amount of internalized transferrin (Tf) bound to TfR
has already reached a steady state by 20 min (Mayor et al.,
1993). On the other hand, FR-TM and FR-TA traf®c in a
morphologically and kinetically identical manner to TfR;
there is no change in the amount and distribution of
internalized PLR bound to FR-TM (Figure 2B) and FR-TA
(data not shown) with respect to endocytosed Tf bound to
its receptor. These data show that retention in the REC in
preference to other recycling membrane proteins requires
the presence of a GPI anchor.
Endocytic retention is relieved upon depletion of
sphingolipids
To determine whether sphingolipids play a role in the
endocytic retention of GPI-APs, we used a well character-
ized sphingolipid synthesis inhibitor, FB1, which inhibits
sphingosine N-acyltransferase (Figure 3; Wang et al.,
Fig. 2. Retention of FR-GPI in the REC requires the GPI anchor. FRaTb-1 (A) and FR-TMTb-1 (B) cells expressing FR-GPI and FR-TM,
respectively, were labeled with PLR and Cy5-Tf for the indicated times and imaged using a wide-®eld microscope. Pseudo-colored merges of PLR
(encoded green) and Cy5-Tf (encoded red) images are shown in the extreme right-hand panel (`Merge'). Images at the two time points in (A) and (B)
were selected for matching total TfR expression and the endosomal PLR ¯uorescence was normalized to surface receptor expression. Note the change
in PLR ¯uorescence in the REC (arrowheads) compared with that in peripheral endosomes in (A) (arrows indicate GEECs) or (B) (arrows indicate
sorting endosomes) between the 20 and 40 min time points. Scale bar represents 10 mm.
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1991; Mays et al., 1995; Stevens and Tang, 1997), to alter
sphingolipid levels in cells. FB1 treatment does not affect
cell viability, and lipid analyses of FB1-treated cells show
that there is a reduction in the amount of all major
sphingolipid classes without affecting cholesterol levels
relative to the untreated controls (Table I). Growing
FRaTb-1 cells in the presence of FB1 resulted in the loss
of endocytic retention of FR-GPI (Figure 4A; compare
®lled and open circles); FR-GPI was recycled to the cell
surface at a rate similar to the rate of TfR recycling (t1/2
~6±8 min), without signi®cantly altering its rate of
internalization (Table II). Addition of short-chain cera-
mide, N-hexanoyl-D-sphingosine (C6-ceramide), to FB1-
treated cells in the continuous presence of FB1 restored the
rate of FR-GPI recycling to control levels (Figure 4B; open
squares), along with a restoration of sphingolipid levels
(Table I).
Table I. Lipid analysis of FB1-treated cells
Lipid Lipid content, nmol/mg protein (mean 6 SD)
Control FB1 FB1 + C6-ceramide
Cholesterol 72.6 6 10.8 76.1 6 6.7 69.3 6 19.4
Triacylglycerol 55.7 6 20.0 51.1 6 34.8 55.1 6 28.3
Phosphatidylcholine 65.5 6 37.0 66.6 6 19.6 93.1 6 46.5
Phosphatidylethanolamine 50.3 6 1.1 54.5 6 9.0 21.0 6 0.8
Phosphatidylserine 3.7 6 1.6 2.9 6 0.8 6.3 6 0.1
Phosphatidylinositol 7.4 6 4.3 7.7 6 4.2 12.8 6 1.7
Sphingomyelin 15.1 6 1.6 5.5 6 1.3 8.4 6 2.9
Ceramides 16.4 6 2.4 10.1 6 2.3 21.7 6 7.3
Galactosylceramide 6.8 6 1.5 3.5 6 0.4 8.3 6 1.1
Sulfatides 3.2 6 1.0 2.2 6 0.7 3.5 6 0.3
The lipid composition of FRaTb-1 cells grown in medium supplemented with the indicated chemicals was measured as described in Materials and
methods. Results are the mean of three separate analyses.
Fig. 3. Schematic of the sphingolipid biosynthesis pathway. The sites
of action of the various sphingolipid inhibitors used in this study and
the location of the sphingolipid synthesis block in the mutant cell line,
LY-B, are indicated by italic text.
Fig. 4. Sphingolipid depletion increases the rate of recycling of FR-
GPI. Fluorescence associated with internalized FR-GPI bound to PLF
at indicated times was normalized to surface receptor levels and plotted
against time in untreated (control; ®lled circles) and FB1-treated (open
circles) FRaTb-1 cells (A and B) and in FB1-treated FRaTb-1 cells
supplemented with exogenous N-hexanoyl-D-sphingosine (C6-cer; open
squares) and N-palmitoyl-DL-erythro-dihydrosphingosine (NPDS; open
triangles). Fluorescence associated with internalized PLF bound to FR-
GPI at the indicated times was normalized to surface receptor levels
and plotted against time in the FR-GPI-expressing LY-B cell line (C)
grown in sphingolipid-de®cient (Sph±; open circles) or sphingolipid-
suf®cient medium (Sph+; ®lled circles). The solid lines in (A)±(C) are
the best ®t for the data points using the kinetic equation described in
Materials and methods. (D) Rate constants of FR-GPI recycling (ke)
under various treatment conditions. Data are derived from two to six
independent experiments for each rate constant determination.
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FB1 treatment leads to a build-up of sphinganines with a
concomitant decrease in ceramide levels (Wang et al.,
1991; see also Figure 3). Either of these changes could
affect signal transduction pathways in cells (Hannun,
1994) leading to an alteration in the kinetics of endocytic
processes (Chen et al., 1995). Therefore, we used
a different drug, D-threo-1-phenyl-2-decanoylamino-
3-morpholino-1-propanol (PDMP), which speci®cally
blocks synthesis of a large class of sphingolipids, the
glycosphingolipids (Inokuchi and Radin, 1987; Inokuchi
et al., 1990), resulting in the accumulation of a different
set of sphingolipid precursors from that found after FB1
treatment (Felding-Habermann et al., 1990). PDMP treat-
ment also leads to acceleration in the rate of FR-GPI
recycling (Figure 4D and Table II). In another approach
we tested whether the rate of FR-GPI recycling was
restored to control levels in FB1-treated cells supple-
mented with a sphingolipid, N-palmitoyl-DL-erythro-
dihydrosphingosine (NPDS). The naturally occurring
erythro isomers of dihydroceramides or their metabolites
are incapable of mediating signaling activity in cells
(Bielawska et al., 1993; Hannun, 1994; Chen et al., 1995).
NPDS restores the rate of FR-GPI recycling to that in
control cells (Figure 4B; open triangles). These data
suggest that sphingolipid signaling is unlikely to be
involved in regulation of endocytic retention of FR-GPI.
However, since sphingolipid intermediates involved in
signaling may remain uncharacterized, we can not rule out
this possibility altogether.
To rule out further that the loss in endocytic retention of
FR-GPI is due to secondary effects of using sphingolipid-
depleting drugs, and that the restoration of retention is a
result of uncharacterized signaling properties of exo-
genous sphingolipid analogs, we examined the recycling
of FR-GPI in a cell line, LY-B, mutant for the serine
palmitoyl transferase enzyme (Hanada et al., 1998; see
Figure 3). LY-B cells do not accumulate any known
signaling-competent sphingolipid precursors, as the block
is in the ®rst step of sphingolipid biosynthesis. These cells
are unable to make the sphingoid base from endogenous
sources, and therefore rely on serum-derived lipids to
supplement their sphingolipid pools (Hanada et al., 1998).
Growing cells in sphingolipid-de®cient medium for 48 h
leads to sphingolipid levels that are 85% lower than in
wild-type cells or cells supplied with exogenous sources of
sphingolipid, without affecting cell viability or the content
of other major phospholipids (Hanada et al., 1998) and
cholesterol (Fukasawa et al., 2000). The rates of FR-GPI
recycling in sphingolipid-replete and sphingolipid-
de®cient conditions were measured in LY-B cell lines
expressing FR-GPI. In cells grown under sphingolipid-
de®cient conditions, recycling of FR-GPI occurred with a
t1/2 of 6±8 min, as compared with 27 min in cells grown
under conditions that restore normal levels of the lipid
(Figure 4C and D). In contrast, the change in the rate of
FR-GPI internalization in LY-B cells was relatively
insigni®cant upon sphingolipid depletion: cells depleted
of sphingolipids internalized FR-GPI ~1.3-fold more
quickly than replete cells. Thus, the loss of endocytic
retention of FR-GPI is not due to secondary effects of the
drug treatments, and its restoration by addition of
exogenous lipids is unlikely to be due to activation of
signaling pathways.
To test whether sphingolipid depletion affects recycling
of other GPI-APs, we determined the rate of DAF
recycling in an FB1-treated DAF-expressing CHO cell
line, DAFTb-1 (Mayor et al., 1998). The rate of DAF
recycling was accelerated upon treatment with FB1
without substantially affecting the rate of internalization
of DAF (Figure 5; Table II), con®rming that the effect of
sphingolipid depletion on endocytic retention of FR-GPI is
not speci®c to the type of GPI-AP molecule being studied.
To ensure that FB1 treatment or addition of exogenous
ceramides to FB1-treated cells did not result in any
qualitative alteration in the endocytic pathway of the FR-
GPI, we analyzed the co-localization of endocytosed
FR-GPI with internalized TfR. Figure 6 shows that
endocytosed FR-GPI and TfR were extensively co-
localized in the REC in untreated (A and B), FB1-treated
(C and D) or C6-ceramide-replenished cells (E and F).
PDMP treatment or growth of the LY-B cell line under
conditions of sphingolipid depletion did not affect co-
localization of FR-GPI and TfR in the REC either (data not
shown). The majority of internalized FR-GPI and TfR
were co-localized in the REC, showing that upon
alteration of sphingolipid levels, exit from the REC
remains the rate-limiting step in recycling. These data
together show that reduction in sphingolipid levels results
in the loss of endocytic retention of GPI-APs in the REC;
replenishment of sphingolipids results in a restoration of
endocytic retention.
Sphingolipid depletion does not affect recycling of
transferrin receptors
To test whether the defect in recycling of GPI-APs
observed upon sphingolipid depletion is speci®c to GPI-
APs or is a result of a generalized acceleration in recycling
rates of all proteins from the REC, we measured the
recycling kinetics of wild-type human TfR and a
C-terminally truncated TfR (d3±59TfR) that lacks the
clathrin internalization motif. The rates of TfR and
d3±59TfR recycling were not affected by treatment with
FB1 (Figure 7A). The rate of recycling of endogenous
hamster TfR in LY-B cells grown in sphingolipid-de®cient
medium was the same as that in sphingolipid-replete
medium (Figure 7B); the rate constants measured are
similar to those of the human TfR in FRaTb-1 and
d3±59TfR in d3±59TRVb cells. These data show that
sphingolipid depletion does not lead to a generalized
increase in the exit rate of proteins from the REC, since
neither those that interact with clathrin coats (TfR) nor
those that do not (d3±59TfR) have altered recycling
kinetics. Furthermore, the extent and distribution of the
TfR in REC were also unaltered (Figure 6). Thus,
sphingolipid depletion speci®cally abolishes the endocytic
retention of GPI-APs in the REC, and does not have a non-
speci®c effect on the kinetics or morphology of the
endocytic pathway of other proteins.
Discussion
GPI-APs are delivered to endocytic compartments
(GEECs) distinct from those containing molecules endo-
cytosed via the clathrin-mediated pathway. Eventually,
GPI-APs are transported to the REC (Mayor et al., 1998).
Thus, the GPI-AP traf®cking pathway merges with the
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clathrin pathway at the REC, providing two sites wherein
GPI-APs may be retained inside the cell, namely GEECs
and REC. In this report we show that the rate-limiting step
in the recycling of endocytosed GPI-APs to the cell surface
is their exit from the REC. These data are consistent with
the co-localization of a large fraction of the endocytosed
GPI-AP at steady state in the REC with other membrane
components, including the TfR (Mayor et al., 1998). Thus,
given the differential rates of exit of GPI-APs compared
with other membrane components from the REC, GPI-APs
must be segregated/sorted in this compartment.
In the secretory pathway, GPI-APs are traf®cked from
the endoplasmic reticulum (ER) to the Golgi via distinct
vesicles (Muniz et al., 2000). The requirement for the GPI
anchor for endocytic retention and the observation that the
recycling of another GPI-AP, DAF, is unaffected by
treatment with a weak base, primaquine, whereas the
recycling of other transmembrane receptors is inhibited by
this treatment (Keller et al., 1992), strongly suggest that
Fig. 5. Rate of recycling of DAF in sphingolipid-depleted cells.
(A) DAF-associated ¯uorescence intensity at the indicated times was
normalized to surface receptors and plotted against time in untreated
(control; ®lled circles) and FB1-treated (FB1; open circles) cells. The
solid lines represent the best ®t for the data points using the kinetic
equation described in Materials and methods. (B) Rate constants for
DAF recycling in treated and untreated cells.
Fig. 6. Endocytic pathway of FR-GPI and TfR in sphingolipid-depleted
cells. FRaTb-1 cells were incubated with PLF and Alexa568-Tf to
steady state, and images of FR-GPI (A, C and E) and TfR (B, D and
F) were collected using a wide-®eld microscope for untreated (A and
B), FB1-treated (C and D) and C6-ceramide-replenished FB1-treated
cells (E and F). Note that the majority of the intracellular FR-GPI is
extensively co-localized with TfR in the REC (arrows). Scale bar
represents 10 mm.
Table II. Effect of sphingolipid depletion on the kinetics of GPI-AP traf®cking
Cell line Membrane marker Treatment Ri/Rsa ke, min±1 (SD)b ki, min±1 (variance)c
FRaTb-1 FR-GPI ± 0.8 (0.04) 0.0237 (0.003) 0.019 (0.003)
FRaTb-1 FR-GPI FB1 0.36 (0.038) 0.092 (0.02) 0.033 (0.008)
FRaTb-1 FR-GPI FB1 + C6-ceramide 0.5 (0.04) 0.026 (0.003) 0.013 (0.002)
FRaTb-1 FR-GPI FB1 + NPDS 0.42 (0.02) 0.024 (0.004) 0.01 (0.002)
DAFTb-1 DAF ± 0.66 (0.1) 0.0273 (0.001) 0.018 (0.003)
DAFTb-1 DAF FB1 0.31 (0.03) 0.088 (0.017) 0.027 (0.006)
FRaTb-1 FR-GPI PDMP ND 0.05 (0.004) ±
FRaTb-1 FR-GPI Compactind 0.41 (0.025)d 0.075 (0.015)d 0.03 (0.001)d
LY-B FR-GPI FBS ND 0.029 (0.0014) ±
LY-B FR-GPI Nutridoma ND 0.097 (0.02) ±
ND, not determined. The data are mean (SD) from at least two independent experiments.
aInternal to surface receptor distribution at steady state, determined as described in Materials and methods.
bRate of recycling, determined as described in Materials and methods.
cRate of internalization [ke 3 (Ri/Rs)].
dData from Mayor et al. (1998).
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GPI-APs may exit the REC via distinct vesicular or tubular
carriers. Regardless of the mode of exit from the REC, the
ability of the GPI anchor to retain proteins in this
compartment reveals an important function of this ubiqui-
tous post-translational modi®cation.
The GPI anchor attaches proteins to the exoplasmic (or
luminal) lea¯et of the cell membrane. It has been
suggested, therefore, that apical sorting and transmem-
brane signaling by different GPI-APs occur by their
association with putative cholesterol- and sphingolipid-
enriched sorting platforms or `rafts' involved in a variety
of sorting and signaling functions (Simons and Ikonen,
1997). Apical transport is affected by depletion of
cholesterol (Hannan and Edidin, 1996) and sphingolipids
(Mays et al., 1995), and cholesterol depletion severely
affects signaling in lymphocytes (Stulnig et al., 1997),
consistent with this hypothesis. Cholesterol depletion
abolishes endocytic retention of GPI-APs without altering
the rate-limiting step and the compartment involved in
recycling (Mayor et al., 1998). The results presented here
show that sphingolipids are likely to play a structural
rather than signaling role in the endocytic retention of
GPI-APs. Therefore, both cholesterol and sphingolipid
depletion serve to abrogate endocytic retention independ-
ently, strongly implicating a raft-based mechanism for
segregation of GPI-APs in the REC.
Although the segregation of cholesterol- and sphingo-
lipid-enriched regions in arti®cial membranes is well
established (for review see Welti and Glaser, 1994; Brown
and London, 1998b; Rietveld and Simons, 1998), the
detection of rafts in cell membranes has been the subject of
intense controversy (Mayor et al., 1994; Edidin, 1997;
Max®eld and Mayor, 1997; Jacobson and Dietrich, 1999).
Single particle tracking (SPT) studies on GPI-APs and
potentially raft-associated lipids have revealed differently
sized regions of con®ned motion (Jacobson and Dietrich,
1999; Pralle et al., 2000; Schutz et al., 2000). Fluorescence
resonance energy transfer (FRET) methodology (Varma
and Mayor, 1998) and classical chemical cross-linking
techniques (Friedrichson and Kurzchalia, 1998) have
demonstrated that at least a fraction of GPI-APs are
present in small clusters at the surface of living cells.
However, experiments using different FRET methodology
have not detected these structures (Kenworthy and Edidin,
1998; Kenworthy et al., 2000). The role of sphingolipids in
the organization of GPI-APs in rafts in cell membranes has
not been explored using these methods.
Other means for studying `rafts' have been based on the
inability of non-ionic detergents to solubilize lipids and
proteins capable of associating with liquid-ordered regions
of the membrane (Harder and Simons, 1997; Brown and
London, 1998b). Detergent-resistant membranes (DRMs)
consisting of cholesterol, sphingolipids, GPI-APs, in¯u-
enza virus hemagglutinin antigen (HA) and other
components have been equated with rafts involved in
sorting processes (Fiedler et al., 1993; Keller and Simons,
1997; Simons and Ikonen, 1997; Brown and London,
1998a). However, studies on the apical targeting of mutant
forms of HA with alterations in the transmembrane region,
and GPI-anchored rat growth hormone chimeras, have
shown that association with DRMs is not suf®cient for
apical delivery (Lin et al., 1998; Benting et al., 1999).
Sphingolipid depletion did not alter the Triton X-100
solubility characteristics of transfected GPI-APs in Fisher
rat thyroid cells, but altered the apical and basolateral
sorting of these proteins (Lipardi et al., 2000). These
observations question the relationship between DRMs and
sorting-competent rafts. Thus, in the absence of convin-
cing biochemical and biophysical evidence, the ability of
cholesterol and sphingolipid depletion to perturb the
sorting propensity of GPI-APs in the REC and Golgi
(Mays et al., 1995; Hannan and Edidin, 1996; Lipardi
et al., 2000) is the strongest evidence for the involvement
of rafts in cellular sorting functions.
A simple mechanism for sorting/retention of proteins in
intracellular traf®cking processes appears to be the
formation of large aggregates in the membrane. Marsh
et al. (1995) have shown that stable-cross-linked TfRs,
independent of their clathrin-binding motif, were retained
in the REC if the cross-linked species contained >10
monomers. Recently, Rivera et al. (2000) have demon-
strated that retention of proteins in the ER is maintained by
regulated aggregation. Therefore, it is likely that func-
tional GPI-AP-containing rafts built by cholesterol and
sphingolipids may be retained in endosomes by similar
principles; cholesterol and sphingolipid depletion may
alter the size and structure of the GPI-AP structures,
abolishing their lateral segregation/sorting in the
membrane.
Endocytic retention of GPI-APs is likely to be physio-
logically relevant. The replacement of the GPI anchor with
Fig. 7. Sphingolipid depletion does not affect the rate of TfR recycling.
(A) Internalized Cy3-Tf ¯uorescence bound to TfR (circles) or
d3±59TfR (triangles) at indicated times was normalized to surface
receptor expression and plotted against time in untreated (control; ®lled
symbols) and FB1-treated (FB1; open symbols) cells, in FRaTb-1 (TfR)
and d3±59TRVb (d3±59TfR) cells, respectively. (B) Internalized Cy5-
Tf ¯uorescence bound to TfR at the indicated times was normalized to
surface receptor expression and plotted against time in LY-B cells
grown in sphingolipid-de®cient (open circle; Sph±) or sphingolipid-
suf®cient medium (®lled circle; Sph+). The solid lines in (A) and (B)
represent the best ®t for the data points using the kinetic equation
described in Materials and methods.
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a transmembrane proteinaceous anchor leads to loss of
endocytic retention of FR-GPI and concomitantly severely
impairs folate uptake (Ritter et al., 1995). Replacement of
the GPI anchor on the cellular prion protein also disrupts
scrapie formation in acidic endosomes (Taraboulos et al.,
1995). Together with the impairment of folate uptake and
scrapie formation upon cholesterol depletion (Chang et al.,
1992; Taraboulos et al., 1995), these data strongly suggest
that endocytic retention via GPI anchoring has physio-
logical consequences. It is likely that rafts in the REC are
the sites where the folate receptor may be in functional
synergy with the anion carriers necessary for transport of
folate across the membrane (Kamen et al., 1991). In the
case of scrapie formation, endocytic retention via rafts
could lead to suf®cient concentration of prion proteins in
the plane of the membrane of an acidic organelle for
long enough to promote conversion. The cholesterol-
and sphingolipid-dependent structural organization of
GPI-APs in cell membranes, therefore, warrant further
experimentation.
Materials and methods
Materials
Fluorescent derivatives of folic acid, Na-pteroyl-Ne-(4¢-¯uorescein-
thiocarbamoyl)-L-lysine (PLF) and PLR were synthesized as described
previously (McAlinden et al., 1991), except that PLR was synthesized
using lissamine rhodamine sulfonyl chloride (Fluka Chemie AG, Buchs,
Switzerland) instead of ¯uorescein isothiocynate. PLR binds saturably to
FR isoforms and is resistant to release at pH 5.0, well below the acidic pH
of endosomes. Nigericin and all ¯uorochromes for conjugation, except
Cy3 and Cy5, (Amersham Pharmacia Biotech) were obtained from
Molecular Probes (Eugene, OR). Tf was puri®ed (Mayor et al., 1993) and
all protein-based reagents were labeled with ¯uorophores according to the
manufacturer's instructions. LDL was prepared from fetal bovine serum
and labeled with 1,1¢-dioctadecyl-3,3,3¢,3¢)-tetramethylindocarbocyanine
perchlorate [`DiI', DiIC18(3)] as previously described (Mayor et al.,
1993). All dichroic mirrors, excitation and emission ®lters were from
Chroma Technology Corp. (Brattleboro, VT). All reagents were obtained
from Sigma Chemical Co. (St Louis, MI) unless indicated otherwise.
Fetal bovine serum (FBS) was obtained from Life Technologies
(Rockville, MD). PDMP was obtained from Matreya, Inc. (Pleasant
Gap, PA). PI-PLC (phosphatidylinositol-speci®c phospholipase C) was a
gift from Martin Low (Columbia University, New York, NY) and Ram
Vishwakarma (National Institute of Immunology, New Delhi). A mouse
monoclonal antibody (mAb) against the human folate receptor, Mov19,
was a gift from Centocor Corp. (Malvern, PA). A mouse mAb against
human DAF (human anti-CD55) was purchased from PharMingen (San
Diego, CA). Anti-human transferrin receptor antibody and Nutridoma-SP
were obtained from Boehringer Mannheim (Roche Diagnostics, Mumbai,
India).
Cells and cell culture
DAF-, FR-GPI-, FR-TM- and d3±59TfR-expressing CHO cells
(DAFTb-1; FRaTb-1, FR-TM-Tb-1 and d3±59TRVb cells, respectively)
were maintained as described previously (Mayor et al., 1998; Varma and
Mayor, 1998). FR-GPI-expressing LY-B lines were obtained by
transfecting LY-B cells (Hanada et al., 1998) with FR-GPI cDNA in
plasmid pMEP4 as previously described (Mayor and Max®eld, 1995).
Transfected LY-B lines were maintained in folate-free HF-12 supple-
mented with 5% FBS, 50 mg/ml hygromycin and 100 mg/ml penicillin±
streptomycin. cDNA for FR-TA was obtained and transfected into
TRVb-1 cells (FR-TA-Tb-1 cells) exactly as described for FR-TM
(Varma and Mayor, 1998).
Fluorescent labeling and co-localization studies
All microscopy was carried out on cells grown on poly(D-lysine)-coated
35 mm cover-slip bottom dishes as previously described (Mayor et al.,
1998). Fluorescent labels were made up to appropriate concentrations in
labeling medium (folate-free HF-12, 0.3 mg/ml NaHCO3, 5% dialyzed
serum, 15 mM HEPES pH 7.2). Cells were washed in medium 1 (150 mM
NaCl, 5 mM KCl, 1 mM CaCl2, 1 mM MgCl2, 20 mM HEPES pH 7.4).
Fluorescent folic acid analogs were removed from their receptors by
multiple washes with ascorbate buffer (140 mM sodium ascorbate, 65 mM
ascorbic acid, 1 mM CaCl2, 1 mM MgCl2 pH 4.5).
Cells expressing FR isoforms were plated in medium containing 5%
dialyzed FBS 3 days prior to labeling. Cell surface labeling was carried
out by incubation of the cells with the indicated ligands for 1 h at 0°C in
labeling medium. Excess label was removed by washing with medium 1
prior to microscopy. Total endosomal receptor labeling was carried out by
incubation of cells with indicated ligands for 3 h at 37°C and then the
surface receptors were stripped off their ligands by treatment with chilled
ascorbate buffer (4 3 15 min at 0°C). This procedure removes >95% of
the cell surface receptors without affecting the labeling of the
endocytosed receptors. Imaging of cells was carried out in the presence
of 10 mM nigericin in a high-potassium buffer (120 mM KCl, 5 mM NaCl,
1 mM CaCl2, 1 mM MgCl2, 20 mM HEPES pH 7.4) to neutralize
endosomal pH.
Co-localization studies were carried out by labeling cells with 10 nM
PLF and 10 mg/ml Alexa-568-Tf for 3 h at 37°C followed by removal of
surface receptors by PI-PLC treatment and imaging on a wide-®eld
system using a 603 objective. Appropriate dichroic and emission ®lters
were used so that there was no detectable cross-over of ¯uorescence
emission for the two ¯uorophores when imaged singly.
Lipid depletions and repletion
Cells were depleted of sphingolipids by growing them in the presence of
40 mg/ml FB1 for 64±68 h before labeling. Sphingolipid analogs were
added by making 1:1 molar mixtures of lipid with defatted bovine serum
albumin. C6-ceramide and NPDS were added at 1 and 5 mM, respectively,
to the FB1-containing culture medium 12 h before imaging. PDMP
treatment was done by growing the cells in 10 mM PDMP in the culture
medium for 64±68 h. Sphingolipid depletion in LY-B lines was carried
out exactly as previously described (Hanada et al., 1998), except that 1%
dialyzed Nutridoma was used in the depletion medium. Dialyzed
Nutridoma has similar effects on cell growth as Nutridoma (Hanada
et al., 1998).
Fluorescence imaging, quanti®cation and processing
Fluorescence imaging was carried out using a wide-®eld imaging system
[Nikon Eclipse TE300 or Diaphot TMD equipped with a digital CCD
camera with a TEK-5123512 D-series back-illuminated chip (Princeton
Instruments, Princeton, NJ)] controlled using Metamorph software. For
all experiments 203 (0.75 n.a.) or 603 (1.4 n.a., oil) objectives (Nikon,
Japan) were used. Fluorescence images were processed using routines in
MetaMorph software following previously described procedures (Mayor
et al., 1993).
To measure the amount of endocytosed FR-GPI, internalized PLF (or
PLR)-¯uorescence from individual cells was normalized against surface-
bound Cy3-Mov19 (or the second-color folate). In the case of DAF,
internalized Cy5-conjugated anti-DAF ¯uorescence was normalized
against surface-bound primary antibody detected via Alexa-488-conju-
gated goat-anti-mouse secondary antibody. In the case of TfR,
internalized Cy5-conjugated Tf ¯uorescence bound to TfR was normal-
ized against the number of cells in a ®eld or surface receptors detected via
Alexa-488- or ¯uorescein isothiocyanate (FITC)-conjugated secondary
antibody against primary antibody bound to surface TfR.
In each experiment, normalized ¯uorescence was calculated from
12±16 ®elds from duplicate dishes for each time point, and the weighted
mean value and the uncertainty in the mean were determined on a per ®eld
basis considering each ®eld (consisting of 5±30 cells) to be an
independent event, as previously described (Mayor et al., 1993).
Measurement of traf®cking rates
In general, the rates of recycling (or exit rates) and internalization were
obtained by determining the rates of approach to steady state of labeling
in the whole cell (or in the GEECs or REC), under conditions where the
cell surface receptors were labeled to saturation at all times in the
experiment. The recycling rate, ke, was determined by ®tting the data to a
single exponent of the form f = a + b [1 ± exp(±ket)], using the method of
least squares provided in SigmaPlot version 4 (SPSS Inc.). The rate of
internalization of FR-GPI or DAF was determined from the ®rst-order
steady-state kinetic equation exactly as described in Mayor et al. (1993).
Rate of GPI-AP recycling
The rate of recycling of FR-GPI to the cell surface was measured as
previously described (Mayor et al., 1998), using either of two assays with
identical results. In both assays, FR-GPI-expressing cells were incubated
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with saturating amounts of the ¯uorescent ligand for the indicated times at
37°C until a steady state of labeling was reached. Subsequently, in one of
the assays (where PLF was used as the ¯uorescent ligand), Cy3-
conjugated Mov19 was used to normalize the amount of surface receptor
expression. In the other assay, surface-bound ¯uorescent ligand (PLF or
PLR) was removed with chilled ascorbate buffer and labeled with
saturating amounts of the second-color ligand on ice to normalize for
surface receptor expression. The rate of DAF recycling was measured
exactly as described (Mayor et al., 1998), except that complete Cy5-
conjugated anti-DAF mouse IgG instead of Fab fragments was used to
label the recycled DAF. Identical rates were obtained using intact
antibody or Fab (data not shown).
Rate of exit from REC and GEECs
The ef¯ux kinetics of FR-GPI from REC (or the GEECs) were determined
using an assay similar to that used for measuring the rate of FR-GPI
recycling from the whole cell, except that REC (or GEEC)-associated
PLR ¯uorescence was quanti®ed at each time point. For this purpose, the
REC in each cell was identi®ed by co-labeling cells at each time point
with a 20 min pulse of Cy5-Tf (10 mg/ml) followed by a 10 min chase in a
Cy5-Tf-free medium containing 20 mM deferroxamine. This protocol
ensures that Tf label is present mainly in the REC (Presley et al., 1993).
Surface-bound PLR was removed using chilled ascorbate buffer. The
cells were then mildly ®xed on ice with 1% paraformaldehyde. The
surface receptors were then bound to PLF and normalized for surface
receptor expression. The cells were imaged for PLR, PLF and Cy5-Tf
using appropriate ®lters. The REC in the Cy5-Tf image was manually
marked using the `draw region' routine available in Metamorph software,
and the PLR ¯uorescence co-localized with this structure was quanti®ed.
The rate of exit of FR-GPI from GEECs was determined from the same
experiment by subtracting the REC-associated PLR ¯uorescence from the
total internalized PLR ¯uorescence. In separate experiments we
determined that the PLR ¯uorescence in peripheral endosomes (not
associated with the REC) was co-localized with the ¯uid-phase marker,
FITC-conjugated dextran, but not with endocytosed Tf and LDL (data not
shown).
Rate of TfR recycling
The rate of recycling of TfR in FRaTb-1, LY-B and d3±59TRVb cells
was measured as described previously (Mayor et al., 1993), except that in
LY-B lines expressing endogenous hamster TfR, 20 mg/ml of Tf was used
to label the receptors.
Lipid analysis
Lipids were extracted and puri®ed from FRaTb-1 as described (Ariga
et al., 1988) with a few modi®cations. Cells (~2.5 3 108) were
sequentially extracted as described (Stevens and Tang, 1997). Neutral
and acidic lipids were resolved on silica HP-TLC plates that had been pre-
run in chloroform±methanol±water (60:35:8, by volume) and heated to
100°C for 30 min. After application of standards and samples, the lipids
were resolved by running the HP-TLC plates ®rst in chloroform±
methanol±acetic acid±formic acid±water (35:15:6:2:1, by volume) to
~12 cm from the origin, followed by hexane±diethyl ether±acetic acid
(65:35:2, by volume) to the top of the plate. The lipids were identi®ed and
quanti®ed as described (Brown and Rose, 1992). They were visualized by
charring with cupric acetate and identi®ed by co-migration with
standards, and quanti®ed by densitometric scanning and comparison
with standards (Ariga et al., 1988).
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